Aditxt Inc (ADTX)

$2.32

+0.72

(+45.01%)

Market is closed - opens 7 PM, 18 Jul 2024

Performance

  • $1.99
    $2.67
    $2.32
    downward going graph

    14.22%

    Downside

    Day's Volatility :25.47%

    Upside

    13.11%

    downward going graph
  • $1.35
    $68.08
    $2.32
    downward going graph

    41.81%

    Downside

    52 Weeks Volatility :98.02%

    Upside

    96.59%

    downward going graph

Returns

PeriodAditxt IncIndex (Russel 2000)
3 Months
-3.73%
0.0%
6 Months
-47.87%
0.0%
1 Year
-86.48%
0.0%
3 Years
-99.95%
-18.2%

Highlights

Market Capitalization
3.2M
Book Value
$5.96
Earnings Per Share (EPS)
-64.83
Wall Street Target Price
61.0
Profit Margin
0.0%
Operating Margin TTM
-14477.47%
Return On Assets TTM
-111.69%
Return On Equity TTM
-838.07%
Revenue TTM
506.4K
Revenue Per Share TTM
0.75
Quarterly Revenue Growth YOY
-63.5%
Gross Profit TTM
166.9K
EBITDA
-31.3M
Diluted Eps TTM
-64.83
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Sell
    0
    0%Buy
    50%Hold
    50%Sell
Based on 6 Wall street analysts offering stock ratings for Aditxt Inc(by analysts ranked 0 to 5 stars)
Based on 6 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
00
6
6
Hold
3
2
2
Sell
3
00
00

Analyst Forecast

What analysts predicted

Upside of 2529.31%

Current $2.32
Target $61.00

Technicals Summary

Sell

Neutral

Buy

Aditxt Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Aditxt Inc
Aditxt Inc
61.11%
-47.87%
-86.48%
-99.95%
-99.98%
Moderna, Inc.
Moderna, Inc.
-6.91%
25.22%
1.18%
-60.44%
769.95%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
4.48%
16.73%
49.42%
85.5%
258.18%
Novo Nordisk A/s
Novo Nordisk A/s
-3.82%
25.91%
69.01%
206.62%
460.98%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
4.51%
12.79%
36.04%
145.12%
174.23%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Aditxt Inc
Aditxt Inc
NA
NA
NA
0.0
-8.38
-1.12
NA
5.96
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.18
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
32.36
32.36
1.46
44.28
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
48.58
48.58
2.36
3.45
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.75
31.75
0.53
17.06
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Aditxt Inc
Aditxt Inc
Sell
$3.2M
-99.98%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$48.0B
769.95%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$120.7B
258.18%
32.36
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$631.0B
460.98%
48.58
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.2B
174.23%
31.75
39.46%

Insights on Aditxt Inc

  • Decreasing Revenue

    Revenue is down for the last 4 quarters, 220.97K → 81.29K (in $), with an average decrease of 26.1% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 4 quarters, -5.68M → -10.96M (in $), with an average decrease of 28.0% per quarter

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 69.0% return, outperforming this stock by 155.5%

  • Vs NVO

    In the last 3 years, Novo Nordisk A/s has given 205.5% return, outperforming this stock by 305.5%

Institutional Holdings

  • Geode Capital Management, LLC

    0.87%
  • Tower Research Capital LLC

    0.13%
  • Group One Trading, LP

    0.04%
  • IFP Advisors, LLC

    0.02%
  • Natixis SA

    0.02%
  • UBS Group AG

    0.01%

Company Information

a biotech company with a mission to accelerate humanity’s transition to the "age of immunity", we are the business busily decoding the human immune system.

Organization
Aditxt Inc
Employees
47
CEO
Mr. Amro A. Albanna
Industry
Health Technology

FAQs